
Opinion|Videos|October 18, 2024
Use of Long-term NMOSD Data in Clinical Practice
Author(s)Sean Pittock, MD
Key Takeaways
- Long-term data aids in optimizing treatment plans by offering insights into efficacy, safety, and patient outcomes over time.
- Staying updated with research findings is essential for integrating long-term data into clinical practice to enhance patient care.
Sean Pittock, MD, discusses how he utilizes long-term data in his clinical practice for treating neuromyelitis optica spectrum disorder and offers advice for physicians on incorporating these insights into patient care.
Advertisement
Episodes in this series

Video content above is prompted by the following:
How are you utilizing these long-term data in your clinical practice, and what advice do you have for physicians?
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Innovative Trial Employs Novel PET Imaging to Track Cladribine’s Effect on Microglial Activation
2
Cladribine Tablets Reduce Treatment Switches, Outpatient Visits, and Health Care Costs in Multiple Sclerosis
3
Comparative Study Reveals Psychiatric Comorbidities Common in MOGAD, MS, and NMOSD, With Distinct Timing Patterns
4
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
5








